Riociguat in the Treatment of Chronic Thromboembolic Pulmonary Hypertension: An Evidence-Based Review of Its Place in Therapy

Chronic thromboembolic pulmonary hypertension (CTEPH) is classified as group-4 pulmonary hypertension caused by organized thrombi in pulmonary arteries and vasculopathy in nonoccluded areas leading to right heart failure and death. In addition to chronic anticoagulation therapy, each patient with CT...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Core Evid
Asıl Yazarlar: Donaldson, Sahai, Ogunti, Richard, Kibreab, Angesom, Mehari, Alem
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove 2020
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7457580/
https://ncbi.nlm.nih.gov/pubmed/32904692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CE.S172791
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller